Tower Research Capital LLC (TRC)
Position in KROS — Keros Therapeutics, Inc.
CIK 1533421
NEW YORK, NY
Position in KROS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$21,036
-$8,749 QoQ
Shares Held
1,966
-27.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#98
of 132 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $49,479,230 across 466 Biotechnology names. KROS ranks #236 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
4,547 | $4,218,570 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
38,206 | $2,845,582 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,537 | $2,815,110 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,292 | $2,131,964 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,927 | $2,108,602 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
6,437 | $1,575,584 | |
| 7 | INSM |
INSMED Inc
|
10,927 | $1,165,036 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
32,746 | $1,158,880 |
All Filings in KROS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,036 | 1,966 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $29,785 | 2,698 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $37,421 | 1,838 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $33,585 | 2,123 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $42,092 | 3,153 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $12,890 | 1,265 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $363,836 | 22,984 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $106,790 | 1,839 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $224,980 | 4,923 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $59,248 | 895 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $328,496 | 8,262 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $20,306 | 637 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $78,993 | 1,966 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $48,677 | 1,140 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $23,337 | 486 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $106,952 | 2,843 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $100,351 | 3,632 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $20,501 | 377 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $98,121 | 1,677 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $19,147 | 484 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $42,894 | 1,010 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $34,591 | 562 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $13,543 | 192 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $246,809 | 6,399 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $13,015 | 347 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||